rs12073221
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000524607.6(CACNA1E):c.434+31358G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 151,984 control chromosomes in the GnomAD database, including 9,381 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.35 ( 9381 hom., cov: 32)
Consequence
CACNA1E
ENST00000524607.6 intron
ENST00000524607.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.00
Publications
3 publications found
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.39 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CACNA1E | XM_017002243.2 | c.434+31358G>C | intron_variant | Intron 2 of 49 | XP_016857732.1 | |||
| CACNA1E | XM_017002244.2 | c.434+31358G>C | intron_variant | Intron 2 of 49 | XP_016857733.1 | |||
| CACNA1E | XM_017002251.1 | c.434+31358G>C | intron_variant | Intron 2 of 49 | XP_016857740.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | ENST00000524607.6 | c.434+31358G>C | intron_variant | Intron 2 of 11 | 5 | ENSP00000432038.2 |
Frequencies
GnomAD3 genomes AF: 0.348 AC: 52782AN: 151866Hom.: 9380 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
52782
AN:
151866
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.347 AC: 52811AN: 151984Hom.: 9381 Cov.: 32 AF XY: 0.345 AC XY: 25617AN XY: 74296 show subpopulations
GnomAD4 genome
AF:
AC:
52811
AN:
151984
Hom.:
Cov.:
32
AF XY:
AC XY:
25617
AN XY:
74296
show subpopulations
African (AFR)
AF:
AC:
16392
AN:
41448
American (AMR)
AF:
AC:
5234
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1447
AN:
3470
East Asian (EAS)
AF:
AC:
722
AN:
5166
South Asian (SAS)
AF:
AC:
1129
AN:
4816
European-Finnish (FIN)
AF:
AC:
3358
AN:
10540
Middle Eastern (MID)
AF:
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23458
AN:
67952
Other (OTH)
AF:
AC:
751
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1781
3562
5343
7124
8905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
516
1032
1548
2064
2580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
792
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.